Leidig, M <br/><br/>
Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study).  [electronic resource] 

 -  Clinical nephrology  Jun 2008 
 - 425-32 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0301-0430 
<br/><br/><label>Standard No.: </label>10.5414/cnp69425  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antihypertensive Agents--therapeutic use<br/>Biphenyl Compounds--therapeutic use<br/>Cross-Over Studies<br/>Female<br/>Humans<br/>Hypertension--complications<br/>Irbesartan<br/>Kidney Failure, Chronic--complications<br/>Male<br/>Middle Aged<br/>Renal Dialysis<br/>Tetrazoles--therapeutic use<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Valsartan